Chris Gregory
Has grant
CIR Deputy Director; Professor of Inflammatory Cell Biology
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Chris Gregory is a Professor of Inflammatory Cell Biology and the Deputy Director at the Centre for Inflammatory Research at the University of Edinburgh, UK. His research focuses on the complex mechanisms of cell death, particularly in relation to cancer, as highlighted in his recent article, "The Apoptosis Paradox in Cancer." With a commitment to advancing understanding in his field, Professor Gregory contributes to both academic scholarship and clinical applications related to inflammatory processes.
Recent Grants
Grant: Close
Pro-oncogenic roles of the Tyro3/Axl/Mer receptor tyrosine kinase axis in non-Hodgkin’s B-lymphoma
Open Date: 2014-04-01
Close Date: 2017-04-01
Grant: Close
Apoptosis and innate immunity in non-Hodgkin’s lymphoma
Open Date: 2013-03-01
Close Date: 2017-03-01
Grant: Close
Qualitative and quantitative analysis of microparticles released from apoptotic lymphoma cells
Open Date: 2011-08-01
Close Date: 2013-02-01
Grant: Close
Apoptosis driven recruitment of macrophages to starry sky B cell lymphomas
Open Date: 2010-10-01
Close Date: 2014-10-01
Grant: Close
Apoptosis and innate immunity in non-Hodgkin's lymphoma
Open Date: 2009-03-01
Close Date: 2013-03-01
Articles (2)
Extracellular vesicles (EVs) are increasingly recognized as critical mediators of intercellular communication, not least during cellular stress or therapy. While EV signalling is well-studied in various tissues, its role in the prepubertal testicular environment is not well understood. Chemotherapy, commonly used in paediatric oncology, poses a significant risk to spermatogonial stem cells (SSCs) and may affect long-term fertility in cancer survivors. The role of EVs in chemotherapy-induced testicular damage in these patients is unknown and may be important for developing new fertility preservation methods. Immortalised murine Sertoli (TM4) and spermatogonial (GC1-spg) cell lines were used to investigate cisplatin-induced changes in EV biogenesis, release, and function in an in vitro model of the prepubertal testicular microenvironment. Our findings indicate that cisplatin significantly increases EV secretion and internalisation by recipient cells. Notably, EVs from cisplatin-exposed Sertoli cells exhibit a novel pro-apoptotic phenotype when co-cultured with chemotherapy-naïve Sertoli cells. Proteomic profiling of these EVs shows enrichment of apoptosis-regulatory proteins including caspases, activating Caspase-3/7 in recipient Sertoli cells. Conversely, germ cells exposed to Sertoli cell-derived EVs displayed reduced levels of apoptosis as well as a chemoprotective role to germ cells undergoing treatment with cisplatin. These findings indicate a dual role for Sertoli cell-derived EVs in mediating (1) apoptosis in Sertoli cells and (2) protection of germ cells following cisplatin exposure. The presence of pro-apoptotic molecules, especially caspases, in chemotherapy-induced Sertoli cell EVs provides mechanism for the induction of somatic cell apoptosis. Furthermore, their protective effects on germ cells demonstrate the complexity of EV-mediated signalling between testicular cell types. Manipulating EV biogenesis and cargo loading could be a promising approach to reduce chemotherapy-related gonadotoxicity and preserve fertility in childhood cancer patients.
Year:
2026
Year:
2022
Collaborators (2)
Michael P Rimmer
Clinical Lecturer
University of Edinburgh
Shannon Stott
Professor and Chair
Boston University
Make your next move.
Prepare your application
Review drafts before you send them.